Okupe Oluyemi 4

What Happened

• Okupe Oluyemi, Chief Financial Officer of Hims & Hers Health, Inc. (HIMS), exercised 7,163 stock options and immediately sold those 7,163 shares on July 6, 2026. The exercise price paid was $5.01 per share (total cost ~$35,887) and the shares were sold at an average weighted price of $36.49 per share (total proceeds ~$261,351). The filing also shows a derivative disposal at $0 related to the conversion of the option into shares.

Key Details

• Transaction dates: July 6, 2026 (exercise and sale); Form 4 filed July 7, 2026 (timely filing).
• Exercise: 7,163 shares @ $5.01 = ~$35,887 paid to exercise options.
• Sale: 7,163 shares @ average $36.49 = ~$261,351 proceeds (price range reported: $36.35–$36.70 per F2).
• 10b5-1 plan: Transactions were effected under a Rule 10b5-1 trading plan adopted May 21, 2025 (F1).
• Vesting note: Options follow a standard vesting schedule (25% at 12 months from Jan 24, 2022, then monthly over 36 months) per footnote F3.
• Shares owned after the transaction: not disclosed in the provided Form 4 excerpt.

Context

• This was an option exercise followed by an immediate sale (a cashless-style outcome): the insider exercised options and sold the resulting shares rather than holding them. Transactions under pre-established 10b5-1 plans are generally scheduled and do not necessarily indicate a change in the insider’s view of the company; they are commonly used to avoid trading-window issues.